Arrythmia clinical trials at University of California Health

1 research study open to eligible people

PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
open to eligible people ages 18 years and up
To investigate the effect of VTA ablation at the time of LVAD implant to see if it can reduce the incidence of VTA after surgery
at UCLA UCSF

Our lead scientists for Arrythmia research studies include Kalyanam Shivkumar Joshua Moss.

Last updated: July 10, 2026

PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients